Q1 2026 DAYBUE net sales US$101m, up 20% from Q1 2025
Released
Latest announcements
Ask a question
Your question will be sent privately to Neuren Pharmaceuticals Limited. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Neuren Pharmaceuticals Limited a question about this announcement.